NCT02489734
- Conditions
- Confusion, Delirium, Delirium on Emergence, +10 more
- Locations
-
Not specified
Clinical trial condition
Neurocognitive Disorders
Explore clinical trials studying Neurocognitive Disorders. Study availability and eligibility vary by location and protocol.
7,783 public trials
1,435 recruiting studies
Neurocognitive Disorders trial results
NCT03475316
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +11 more
- Locations
-
- Albert Einstein College of Medicine The Bronx, New York, United States
Completed
Telemedicine-based, Multidisciplinary-team, Intervention to Reduce Unnecessary Hospitalizations
NCT03378245
- Conditions
- Alzheimer Disease, Behavior, Behavioral Symptoms, +12 more
- Locations
-
- University of Kentucky Lexington, Kentucky, United States
NCT02106065
- Conditions
- Behavior, Behavioral Symptoms, Brain Diseases, +9 more
- Locations
-
- VA Palo Alto Health Care System, Palo Alto, CA Palo Alto, California, United States
NCT04120103
- Conditions
- Aberrant Motor Behavior in Dementia, Behavior, Behavioral Symptoms, +13 more
- Locations
-
- Cemile KÜTMEÇ YILMAZ Merkez, Aksaray, Turkey (Türkiye)
NCT03244917
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Brain Diseases, +7 more
- Locations
-
- Hebrew SeniorLife Boston, Massachusetts, United States
Completed
A Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease
NCT03117738
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- ATP Clinical Research Costa Mesa, California, United States
- Syrentis Clinical Research Santa Ana, California, United States
- Valden Medical Honolulu, Hawaii, United States
NCT03081546
- Conditions
- Cognition Disorders, Cognitive Dysfunction, Healthy Controls, +3 more
- Locations
-
- University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
NCT02035865
- Conditions
- Cognition Disorders, Mental Disorders, Neurocognitive Disorders, +1 more
- Locations
-
- Oslo University Hospital Oslo, Norway
Completed
Evaluation of Lithium as a Glycogen-Synthase-Kinase-3 (GSK-3) Inhibitor in Mild Cognitive Impairment
NCT02601859
- Conditions
- Cognition Disorders, Cognitive Dysfunction, Mental Disorders, +2 more
- Locations
-
Not specified